Hippo (HIPO) Competitors $24.38 -0.23 (-0.95%) Closing price 04/17/2025 03:59 PM EasternExtended Trading$24.36 -0.02 (-0.07%) As of 04/17/2025 05:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HIPO vs. LMND, SKWD, HG, ROOT, FIHL, CLOV, TRUP, BOW, IGIC, and TIPTShould you be buying Hippo stock or one of its competitors? The main competitors of Hippo include Lemonade (LMND), Skyward Specialty Insurance Group (SKWD), Hamilton Insurance Group (HG), Root (ROOT), Fidelis Insurance (FIHL), Clover Health Investments (CLOV), Trupanion (TRUP), Bowhead Specialty (BOW), International General Insurance (IGIC), and Tiptree (TIPT). These companies are all part of the "insurance" industry. Hippo vs. Lemonade Skyward Specialty Insurance Group Hamilton Insurance Group Root Fidelis Insurance Clover Health Investments Trupanion Bowhead Specialty International General Insurance Tiptree Lemonade (NYSE:LMND) and Hippo (NYSE:HIPO) are both small-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their community ranking, profitability, media sentiment, analyst recommendations, institutional ownership, risk, earnings, valuation and dividends. Do institutionals & insiders have more ownership in LMND or HIPO? 80.3% of Lemonade shares are owned by institutional investors. Comparatively, 43.0% of Hippo shares are owned by institutional investors. 12.5% of Lemonade shares are owned by insiders. Comparatively, 11.4% of Hippo shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Do analysts rate LMND or HIPO? Lemonade presently has a consensus target price of $28.00, indicating a potential upside of 4.49%. Hippo has a consensus target price of $28.67, indicating a potential upside of 17.60%. Given Hippo's stronger consensus rating and higher probable upside, analysts clearly believe Hippo is more favorable than Lemonade.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lemonade 4 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.50Hippo 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Which has more risk and volatility, LMND or HIPO? Lemonade has a beta of 2.13, meaning that its stock price is 113% more volatile than the S&P 500. Comparatively, Hippo has a beta of 1.49, meaning that its stock price is 49% more volatile than the S&P 500. Does the media favor LMND or HIPO? In the previous week, Hippo had 10 more articles in the media than Lemonade. MarketBeat recorded 10 mentions for Hippo and 0 mentions for Lemonade. Lemonade's average media sentiment score of 0.50 beat Hippo's score of 0.15 indicating that Lemonade is being referred to more favorably in the media. Company Overall Sentiment Lemonade Positive Hippo Neutral Which has stronger valuation and earnings, LMND or HIPO? Lemonade has higher revenue and earnings than Hippo. Hippo is trading at a lower price-to-earnings ratio than Lemonade, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLemonade$526.50M3.71-$236.90M-$2.85-9.40Hippo$372.10M1.64-$273.10M-$1.74-14.01 Is LMND or HIPO more profitable? Hippo has a net margin of -37.94% compared to Lemonade's net margin of -43.51%. Lemonade's return on equity of -32.85% beat Hippo's return on equity.Company Net Margins Return on Equity Return on Assets Lemonade-43.51% -32.85% -12.59% Hippo -37.94%-36.38%-8.36% Does the MarketBeat Community favor LMND or HIPO? Lemonade received 11 more outperform votes than Hippo when rated by MarketBeat users. However, 41.46% of users gave Hippo an outperform vote while only 28.87% of users gave Lemonade an outperform vote. CompanyUnderperformOutperformLemonadeOutperform Votes2828.87% Underperform Votes6971.13% HippoOutperform Votes1741.46% Underperform Votes2458.54% SummaryLemonade and Hippo tied by winning 9 of the 18 factors compared between the two stocks. Get Hippo News Delivered to You Automatically Sign up to receive the latest news and ratings for HIPO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HIPO vs. The Competition Export to ExcelMetricHippoFire, marine, & casualty insurance IndustryFinance SectorNYSE ExchangeMarket Cap$611.42M$47.71B$10.83B$18.43BDividend YieldN/A2.41%5.98%4.20%P/E Ratio-4.6811.2021.6731.10Price / Sales1.645.4625.4326.58Price / CashN/A16.8117.6117.54Price / Book1.532.242.564.30Net Income-$273.10M$4.16B$1.03B$1.02B7 Day Performance9.17%1.74%1.86%1.42%1 Month Performance-7.15%-0.75%-3.72%-7.33%1 Year Performance23.37%21.45%535.22%2.27% Hippo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HIPOHippo1.4901 of 5 stars$24.38-0.9%$28.67+17.6%+20.1%$611.42M$372.10M-4.68620Short Interest ↓Gap DownLMNDLemonade1.9299 of 5 stars$28.10-0.3%$31.00+10.3%+70.1%$2.05B$526.50M-9.241,370SKWDSkyward Specialty Insurance Group3.6617 of 5 stars$47.98-3.1%$56.25+17.2%+58.1%$1.94B$1.15B14.63400HGHamilton Insurance Group3.1487 of 5 stars$18.32-4.8%$23.80+29.9%+38.5%$1.86B$2.38B4.10550High Trading VolumeROOTRoot1.0023 of 5 stars$112.76+0.3%$88.33-21.7%+141.5%$1.71B$1.18B-91.67760FIHLFidelis Insurance3.3026 of 5 stars$14.93-3.5%$20.57+37.8%-13.6%$1.67B$2.42B3.7777Short Interest ↑CLOVClover Health Investments3.2063 of 5 stars$3.21-3.6%$4.83+50.6%+479.1%$1.64B$1.37B-16.05680Positive NewsTRUPTrupanion3.4105 of 5 stars$34.45+0.3%$46.60+35.3%+60.3%$1.46B$1.29B-149.781,142News CoveragePositive NewsGap UpBOWBowhead Specialty1.6635 of 5 stars$37.33-2.4%$33.60-10.0%N/A$1.22B$425.59M0.00193Analyst ForecastShort Interest ↑News CoverageHigh Trading VolumeIGICInternational General Insurance4.116 of 5 stars$21.29-5.8%$31.50+48.0%+83.3%$978.36M$526M6.96290Short Interest ↓Positive NewsHigh Trading VolumeTIPTTiptree1.575 of 5 stars$21.09-3.2%N/A+44.1%$785.79M$2.04B21.741,470Short Interest ↓High Trading Volume Related Companies and Tools Related Companies Lemonade Alternatives Skyward Specialty Insurance Group Alternatives Hamilton Insurance Group Alternatives Root Alternatives Fidelis Insurance Alternatives Clover Health Investments Alternatives Trupanion Alternatives Bowhead Specialty Alternatives International General Insurance Alternatives Tiptree Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:HIPO) was last updated on 4/18/2025 by MarketBeat.com Staff From Our Partners100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored‘Wheels Are Falling Off’ the U.S. Stock MarketThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hippo Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hippo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HIPO Stock Free HIPO Stock Alerts